Completed
Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design
NCT01945359
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Rocky Mountain MS Research Group Salt Lake City, Utah, United States